| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Matrilysin ELISA Kit; Matrin ELISA Kit; Matrix Metalloproteinase 7 ELISA Kit; Matrix metalloproteinase-7 ELISA Kit; MMP 7 ELISA Kit; MMP-7 ELISA Kit; MMP7 ELISA Kit; MMP7_HUMAN ELISA Kit; MPSL1 ELISA Kit; PUMP 1 ELISA Kit; Pump 1 protease ELISA Kit; Pump-1 protease ELISA Kit; PUMP1 ELISA Kit; Uterine matrilysin ELISA Kit; Uterine metalloproteinase ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Matrix metalloproteinase 7 (MMP7) is a biological molecule commonly studied in cancer research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P09237
Biological context
Researchers often monitor Matrix metalloproteinase 7 in serum, plasma, and tissue homogenates to better understand themes such as tumor microenvironment biology, cell proliferation and apoptosis, and metastasis and invasion pathways. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Matrix metalloproteinase 7 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cell-cycle regulators, invasion/ECM markers, and immune-oncology mediators) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Matrix metalloproteinase 7 may also appear under names such as Matrilysin and Matrin. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Matrix metalloproteinase 7 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Evaluating the diagnostic and therapeutic significance of KL-6 in patients with interstitial lung diseases
T Wang,/,2024
Insights into ascending aortic aneurysm: Interactions between biomechanical properties of the aortic wall and tissue biomarkers
SI Sazonova,/,2023
Ex Vivo Analysis of an Association of Mechanical Strength of Dilated Ascending Aorta with Tissue Matrix Metalloproteinases and Cytokines
SI Sazonova,Bulletin of experimental biology and medicine,2023
Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia
B Wu,European journal of pediatrics,2022
CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate
A Batool,Cancers,2020
Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer
Linyan Zhu.et al,Onco Targets Ther,2018